David Kirske Cti Biopharma Corp (CTIC) insider trading activity
David Kirske is EVP, Chief Financial Officer of CTI BIOPHARMA CORP. Currently has a direct ownership of 0 shares of CTIC, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2020, when has been sold 3,798 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $3,722. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
DK
David Kirske
EVP, Chief Financial Officer
Seattle, WA